Stocks › BBAR
Banco BBVA BBAR
US equityMarket cap rank #2752
$8.78 −$0.36 (-3.94%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.78 0.00%
Open$8.92
Prev close$9.14
Day range$8.66 – $9.17
Volume1.16M
Market cap$1.79B
P/E (TTM)8.2
Dividend yield4.15%
Fundamentals
Latest reported quarter: Q2, ended Jun 2026 · reported in ARS
RevenueARS 1.21T+13.3% YoY
Net profitARS 131.56B+65.2% YoY
Diluted EPSARS 619.97+71.3% YoY
Free cash flow-ARS 51.75B-107.4% YoY
Operating cash flow-ARS 13.50B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Net margin10.0%
Return on equity9.6%
Return on assets1.4%
Liabilities / assets84.6%
Cash & investmentsARS 4.05T
Total debtARS 1.48T
Net cash (debt)ARS 2.57T
Free cash flow / sales21.0%
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
Income statement
| Line item | 2026 Q2 (ARS) |
2026 Q1 (ARS) |
2025 ANNUAL (ARS) |
2025 Q4 (ARS) |
2025 Q3 (ARS) |
|---|---|---|---|---|---|
| Total Operating Revenue | ARS 1.21T | ARS 1.18T | ARS 3.05T | ARS 584.56B | ARS 846.37B |
| Net Interest Income | ARS 929.56B | ARS 898.40B | ARS 2.79T | ARS 927.66B | ARS 601.98B |
| -Interest Income | ARS 1.47T | ARS 1.55T | ARS 5.37T | ARS 1.87T | ARS 1.33T |
| -Interest Expense | ARS 536.48B | ARS 650.24B | ARS 2.58T | ARS 939.55B | ARS 727.57B |
| Non-Interest Income | ARS 276.95B | ARS 283.37B | ARS 261.23B | -ARS 343.10B | ARS 244.39B |
| -Fees and Commissions | ARS 201.11B | ARS 192.38B | ARS 588.37B | ARS 192.21B | ARS 153.84B |
| -Foreign Exchange Trading Gains | ARS 48.56B | ARS 53.33B | ARS 193.09B | ARS 65.84B | ARS 60.65B |
| -Other Non-Interest Income | ARS 18.32B | ARS 19.13B | ARS 51.61B | ARS 6.14B | ARS 30.03B |
| -Gain Loss on Sale of Assets | ARS 8.96B | ARS 18.53B | -ARS 571.83B | -ARS 607.29B | -ARS 134.51M |
| Credit Losses Provision | -ARS 298.62B | -ARS 241.13B | ARS 33.03B | ARS 489.96B | -ARS 203.02B |
| Non-Interest Expense | ARS 567.82B | ARS 586.33B | ARS 2.02T | ARS 611.23B | ARS 470.84B |
| Selling and Admin Expenses | ARS 340.48B | ARS 339.19B | ARS 1.19T | ARS 334.58B | ARS 277.37B |
| -Selling & Marketing Expense | ARS 7.88B | ARS 11.73B | ARS 50.89B | ARS 13.04B | ARS 10.07B |
| -General & Admin Expense | ARS 332.60B | ARS 327.46B | ARS 1.14T | ARS 321.55B | ARS 267.30B |
| Depreciation & Amortization & Depletion | ARS 36.75B | ARS 32.09B | ARS 111.10B | ARS 37.98B | ARS 24.78B |
| -Depreciation & Amortization | ARS 36.75B | ARS 32.09B | ARS 111.10B | ARS 37.98B | ARS 24.78B |
| Other Non-Interest Expenses | ARS 190.59B | ARS 215.05B | ARS 717.02B | ARS 238.67B | ARS 168.68B |
| Other Income (Expense) | -ARS 158.22B | -ARS 222.35B | -ARS 550.27B | -ARS 248.16B | -ARS 111.16B |
| Income from Associates & Other Participating Interests | ARS 318.73M | -ARS 3.75B | ARS 11.95B | ARS 3.64B | ARS 3.21B |
| Special Income (Charges) | -ARS 158.54B | -ARS 218.59B | -ARS 562.23B | -ARS 251.79B | -ARS 114.37B |
| -Less:Other Special Charges | ARS 176.69B | ARS 218.59B | ARS 571.21B | ARS 174.48B | ARS 110.95B |
| -Less:Write Off | -ARS 18.16B | – | – | – | ARS 3.43B |
| Pretax Profit | ARS 181.85B | ARS 131.98B | ARS 519.82B | ARS 215.13B | ARS 61.35B |
| Tax | ARS 50.29B | ARS 46.75B | ARS 187.25B | ARS 75.48B | ARS 23.28B |
| Net Profit | ARS 131.56B | ARS 85.22B | ARS 332.57B | ARS 139.65B | ARS 38.07B |
| Profit from Continuing Operations | ARS 131.56B | ARS 85.22B | ARS 332.57B | ARS 139.65B | ARS 38.07B |
| Minority Interests | ARS 4.94B | ARS 6.80B | ARS 17.43B | ARS 6.36B | ARS 2.99B |
| Net Income to Parent Company | ARS 126.62B | ARS 78.42B | ARS 315.14B | ARS 133.29B | ARS 35.09B |
| Net Income to Common Stockholders | ARS 126.62B | ARS 78.42B | ARS 315.14B | ARS 133.29B | ARS 35.09B |
| Basic EPS | ARS 619.97 | ARS 383.97 | ARS 1,543.03 | ARS 264.00 | ARS 171.79 |
| Diluted EPS | ARS 619.97 | ARS 383.97 | ARS 1,543.03 | ARS 264.00 | ARS 171.79 |
| Dividend Per Share | ARS 173.91 | ARS 149.89 | ARS 216.31 | ARS 140.55 | ARS 45.86 |
| -Less:Restructuring and Mergern & Acquisition | – | – | ARS 775.16M | – | – |
| -Less:Impairment of Capital Assets | – | – | -ARS 9.75B | – | – |
Balance sheet
| Line item | 2026 Q2 (ARS) |
2026 Q1 (ARS) |
2025 ANNUAL (ARS) |
2025 Q4 (ARS) |
2025 Q3 (ARS) |
|---|---|---|---|---|---|
| Total Assets | ARS 28.14T | ARS 25.71T | ARS 25.41T | ARS 25.41T | ARS 22.17T |
| Cash, Cash Equivalents & Federal Funds Sold | ARS 4.08T | ARS 4.01T | ARS 4.75T | ARS 4.75T | ARS 3.83T |
| -Cash and Cash Equivalents | ARS 4.05T | ARS 4.01T | ARS 4.75T | ARS 4.75T | ARS 3.83T |
| -Money Market Investments | ARS 25.99B | – | – | – | – |
| Securities Investment | ARS 5.37T | ARS 4.07T | ARS 2.80T | ARS 2.80T | ARS 3.13T |
| -Available for Sale Securities | ARS 5.35T | ARS 4.05T | ARS 2.80T | ARS 2.80T | ARS 3.12T |
| -Short Term Investments | ARS 16.26B | ARS 11.07B | – | – | ARS 9.17B |
| Long Term Equity Investment | ARS 49.04B | ARS 43.08B | ARS 38.57B | ARS 38.57B | ARS 35.40B |
| Derivative Assets | ARS 7.97B | ARS 72.45B | ARS 38.87B | ARS 38.87B | ARS 57.69B |
| Net Loan | ARS 16.35T | ARS 15.02T | ARS 14.41T | ARS 14.41T | ARS 12.53T |
| -Gross Loan | ARS 17.20T | ARS 15.82T | ARS 15.03T | ARS 15.03T | ARS 12.96T |
| -Allowance for Loans and Lease Losses | ARS 853.31B | ARS 798.27B | ARS 617.15B | ARS 617.15B | ARS 431.94B |
| Receivables | ARS 50.18B | ARS 242.11B | ARS 192.74B | ARS 192.74B | ARS 268.97B |
| -Other Receivables | ARS 50.18B | ARS 242.11B | ARS 192.74B | ARS 192.74B | ARS 268.97B |
| Net PPE | ARS 1.03T | ARS 970.04B | ARS 896.65B | ARS 896.65B | ARS 814.27B |
| -Gross PPE | ARS 1.03T | ARS 970.04B | ARS 1.27T | ARS 1.27T | ARS 814.27B |
| Goodwill and Other Intangible Assets | ARS 159.23B | ARS 137.81B | ARS 119.34B | ARS 119.34B | ARS 101.96B |
| -Other Intangible Assets | ARS 159.23B | ARS 137.81B | ARS 119.34B | ARS 119.34B | ARS 101.96B |
| Prepaid Assets | ARS 81.66B | ARS 117.66B | ARS 113.92B | ARS 113.92B | ARS 95.20B |
| Foreclosed Assets | ARS 244.30M | ARS 229.74M | ARS 210.76M | ARS 210.76M | ARS 196.18M |
| Deferred Assets | ARS 28.05B | ARS 91.01B | ARS 66.04B | ARS 66.04B | ARS 117.01B |
| Assets Held for Sale | ARS 1.75B | ARS 1.64B | ARS 3.24B | ARS 3.24B | ARS 3.85B |
| Other Assets | ARS 944.03B | ARS 943.63B | ARS 1.98T | ARS 1.98T | ARS 1.19T |
| Total Liabilities | ARS 23.81T | ARS 21.69T | ARS 21.87T | ARS 21.87T | ARS 19.18T |
| Total Deposits | ARS 19.21T | ARS 17.46T | ARS 17.21T | ARS 17.21T | ARS 15.36T |
| Derivative Product Liabilities | ARS 6.67B | ARS 13.99B | ARS 6.50B | ARS 6.50B | ARS 74.16B |
| Short-Term Debt and Capital Lease Obligation | ARS 8.55B | ARS 5.28B | ARS 3.38B | ARS 3.38B | ARS 2.82B |
| -Current Capital Lease Obligation | ARS 8.55B | ARS 5.28B | ARS 3.38B | ARS 3.38B | ARS 2.82B |
| Trading Liabilities | ARS 73.66B | ARS 35.12B | – | – | – |
| Payables | ARS 543.37B | ARS 582.60B | ARS 638.23B | ARS 638.23B | ARS 465.71B |
| -Accounts Payable | ARS 209.48M | ARS 196.07M | ARS 188.53M | ARS 188.53M | ARS 203.96M |
| -Total Tax Payable | ARS 168.60B | ARS 308.94B | ARS 311.66B | ARS 311.66B | ARS 108.69B |
| -Dividends Payable | ARS 48.17B | ARS 0.00 | ARS 11.80B | ARS 11.80B | ARS 21.88B |
| -Other Payable | ARS 326.39B | ARS 273.46B | ARS 314.58B | ARS 314.58B | ARS 334.93B |
| Long Term Debt and Capital Lease Obligation | ARS 1.48T | ARS 1.29T | ARS 1.49T | ARS 1.49T | ARS 985.95B |
| -Long Term Debt | ARS 1.43T | ARS 1.24T | ARS 1.44T | ARS 1.44T | ARS 943.35B |
| -Long Term Capital Lease Obligation | ARS 46.58B | ARS 46.82B | ARS 48.12B | ARS 48.12B | ARS 42.59B |
| Non-Current Liabilities | ARS 52.86B | ARS 51.57B | ARS 50.31B | ARS 50.31B | ARS 50.46B |
| Employee Benefits | ARS 158.73B | ARS 127.13B | ARS 152.73B | ARS 152.73B | ARS 159.89B |
| Non-Current Deferred Liabilities | ARS 69.71B | ARS 74.51B | ARS 98.75B | ARS 98.75B | ARS 82.85B |
| Other Liabilities | ARS 2.21T | ARS 1.98T | ARS 1.75T | ARS 1.75T | ARS 1.70T |
| Total Equity | ARS 4.33T | ARS 4.02T | ARS 3.54T | ARS 3.54T | ARS 2.98T |
| Stockholders' Equity | ARS 4.19T | ARS 3.90T | ARS 3.43T | ARS 3.43T | ARS 2.92T |
| Capital Stock | ARS 612.71M | ARS 612.71M | ARS 612.71M | ARS 612.71M | ARS 612.71M |
| -Common Stock | ARS 612.71M | ARS 612.71M | ARS 612.71M | ARS 612.71M | ARS 612.71M |
| Retained Earnings | ARS 210.35B | ARS 352.02B | ARS 2.24T | ARS 2.24T | ARS 181.86B |
| Gains/Losses Not Affecting Retained Earnings | ARS 2.58T | ARS 2.23T | -ARS 7.41B | -ARS 7.41B | ARS 1.63T |
| Other Equity Interests | ARS 1.40T | ARS 1.31T | ARS 1.19T | ARS 1.19T | ARS 1.11T |
| Minority Interests | ARS 138.73B | ARS 128.41B | ARS 111.08B | ARS 111.08B | ARS 62.38B |
| Federal Funds Purchased and Securities Sold Under Agreement to Repurchase | – | ARS 66.90B | ARS 468.23B | ARS 468.23B | ARS 300.57B |
| -Accumulated Depreciation | – | – | -ARS 373.19B | -ARS 373.19B | – |
| Additional Paid-In Capital | – | – | ARS 6.74B | ARS 6.74B | – |
Cash flow
| Line item | 2026 Q2 (ARS) |
2026 Q1 (ARS) |
2025 ANNUAL (ARS) |
2025 Q4 (ARS) |
2025 Q3 (ARS) |
|---|---|---|---|---|---|
| Operating Cash Flow | -ARS 13.50B | -ARS 5.24B | ARS 1.00T | ARS 719.48B | ARS 229.89B |
| Net cash flow from continuing operations | -ARS 13.50B | -ARS 5.24B | ARS 1.00T | ARS 1.12T | -ARS 166.80B |
| Net Income from Continuing Operations | ARS 190.78B | ARS 131.98B | ARS 519.82B | ARS 215.13B | -ARS 1.98B |
| Gain/Loss from Continuing Operations | ARS 606.70B | ARS 390.84B | ARS 387.73B | ARS 672.43B | -ARS 527.34B |
| Depreciation & Depletion & Amortization | ARS 38.92B | ARS 32.09B | ARS 111.10B | ARS 37.95B | ARS 12.24B |
| Other Non-Cash Items | ARS 166.64B | ARS 240.62B | -ARS 2.35T | -ARS 2.76T | ARS 22.71B |
| Change in Working Capital | -ARS 732.97B | -ARS 1.04T | -ARS 714.16B | -ARS 33.99B | ARS 254.44B |
| -Change in Loans | -ARS 1.82T | -ARS 1.28T | -ARS 7.74T | -ARS 1.81T | -ARS 546.22B |
| -Change in Other Current Assets | -ARS 73.28B | -ARS 54.76B | ARS 663.84M | ARS 78.80B | -ARS 49.60B |
| -Change in Other Current Liabilities | ARS 348.44B | ARS 191.18B | – | – | -ARS 115.40B |
| -Change in Other Working Capital | ARS 810.09B | ARS 101.26B | ARS 7.03T | ARS 2.40T | ARS 965.66B |
| Net cash flow from investing | -ARS 32.17B | -ARS 26.63B | -ARS 240.57B | -ARS 137.37B | -ARS 34.07B |
| Net Cash Flow from Continuing Investing Activities | -ARS 32.17B | -ARS 26.63B | -ARS 240.57B | -ARS 137.37B | -ARS 34.07B |
| Net PPE Purchase and Sale | -ARS 38.26B | -ARS 26.50B | -ARS 216.83B | -ARS 111.66B | -ARS 35.88B |
| Net Other Investing Changes | ARS 6.09B | -ARS 127.92M | -ARS 2.01B | -ARS 3.99B | ARS 1.81B |
| Financing Cash Flow | ARS 71.99B | -ARS 360.40B | ARS 939.87B | ARS 403.04B | -ARS 10.91B |
| Net Cash Flow from Continuing Financing Activities | ARS 71.99B | -ARS 360.40B | ARS 939.87B | ARS 403.04B | -ARS 10.91B |
| Net Issuance Payments of Debt | ARS 28.30B | -ARS 238.75B | ARS 753.87B | ARS 498.64B | -ARS 275.39B |
| Cash Dividends Paid | -ARS 24.56B | -ARS 7.02B | -ARS 17.00B | -ARS 7.06B | -ARS 5.42B |
| Net Other Financing Activities | ARS 68.25B | -ARS 114.63B | ARS 203.01B | -ARS 88.54B | ARS 269.90B |
| Ending Cash Balance | ARS 4.05T | ARS 4.01T | ARS 4.75T | ARS 4.75T | ARS 3.83T |
| Net Change in Cash | ARS 26.33B | -ARS 392.27B | ARS 1.70T | ARS 985.15B | ARS 184.91B |
| Beginning Cash Balance | ARS 4.01T | ARS 5.20T | ARS 3.71T | ARS 3.83T | ARS 4.43T |
| Effect of Exchange Rate Changes | -ARS 41.54B | -ARS 390.77B | ARS 341.69B | ARS 57.00B | ARS 198.66B |
| Free Cash Flow | -ARS 51.75B | -ARS 31.75B | ARS 783.46B | ARS 607.82B | ARS 194.01B |
| Net Business Purchase and Sale | – | – | -ARS 25.54B | – | – |
No comments yet — be the first to weigh in on BBAR.
Sign in to join the discussion.